Follow The Filings

Alphabet Inc.

Mountain View, CA 4 processed 13Fs on this site, 2025 Q3 to 2026 Q2

  • $99.1B
  • 28 holdings
  • 2026 Q2
  • +2367.2% QoQ
  • Top 5 98.5%

Portfolio

2026 Q2, filed 8/7/2026, top 12 of 28 holdings

Top 5 98.5%, top 10 99.5%

  1. SPCX, Space Exploration 95.0%
  2. PL, Planet Labs PBC 1.2%
  3. ASTS, Ast Spacemobile 0.8%
  4. CME, CME Group 0.8%
  5. ARM, Arm Holdings 0.7%
  6. RVMD, Revolution Medicines 0.5%
  7. Freshworks 0.2%
  8. PBLS, Parabilis Medicines 0.1%
  9. TEM, Tempus AI 0.1%
  10. GTLB, Gitlab 0.1%
  11. PATH, Uipath 0.1%
  12. LIFE, Ethos Technologies 0.1%
  13. Other 0.3%

AUM over time

2026 Q2 $99.1B +2367.2% QoQ
2025 Q3: $2.4B 2025 Q3: $2.4B
Q3 2025
2025 Q4: $2.6B, +7.1% QoQ 2025 Q4: $2.6B, +7.1% QoQ
Q4
2026 Q1: $4B, +55.7% QoQ 2026 Q1: $4B, +55.7% QoQ
Q1 2026
2026 Q2: $99.1B, +2367.2% QoQ 2026 Q2: $99.1B, +2367.2% QoQ
Q2

Book

2025 Q3, filed 7 Nov, long equity only

Download CSV Download Excel
ASTS, Ast Spacemobile 18.22% Hold 8,943,486 $49.08 $439M
PL, Planet Labs PBC 17.21% Hold 31,942,641 $12.98 $415M
ARM, Arm Holdings 11.52% Hold 1,960,784 $141.49 $277M
Metsera 8.22% Hold 3,783,528 $52.33 $198M
RVMD, Revolution Medicines 8.01% Hold 4,133,277 $46.70 $193M
Freshworks 7.92% Hold 16,206,643 $11.77 $191M
TEM, Tempus AI 5.20% Hold 1,551,102 $80.71 $125M
GTLB, Gitlab 5.10% Hold 2,724,712 $45.08 $123M
PATH, Uipath 3.91% Hold 7,034,337 $13.38 $94M
PRME, Prime Medicine 3.81% Hold 16,562,498 $5.54 $92M
DXCM, DexCom 2.90% Hold 1,036,937 $67.29 $70M
MAZE, Maze Therapeutics 2.60% Hold 2,412,471 $25.93 $63M
BBOT 1.36% Hold 2,823,126 $11.58 $33M
FIG, Figma 0.46% Hold 215,582 $51.87 $11M
GLUE, Monte Rosa Therapeutics 0.45% Hold 1,464,015 $7.41 $11M
Sana Biotechnology 0.41% Hold 2,812,500 $3.55 $10M
OSCR, Oscar Health 0.38% Hold 481,988 $18.93 $9.1M
DNTH, Dianthus Therapeutics 0.34% Hold 208,697 $39.35 $8.2M
Relay Therapeutics 0.34% Hold 1,568,753 $5.22 $8.2M
BEAM, Beam Therapeutics 0.32% Hold 321,604 $24.27 $7.8M
Vera Therapeutics 0.29% Hold 241,264 $29.06 $7M
LYEL, Lyell Immunopharma 0.20% Hold 293,256 $16.24 $4.8M
FHTX, Foghorn Therapeutics 0.10% Hold 500,901 $4.89 $2.4M
WGS, Genedx 0.10% Hold 22,711 $107.74 $2.4M
TSHA, Taysha Gene Therapies 0.09% Hold 640,882 $3.27 $2.1M
Tscan Therapeutics 0.08% Hold 1,077,080 $1.82 $2M
Holding 0.08% Hold 1,513,644 $1.25 $1.9M
Spero Therapeutics 0.07% Hold 889,979 $1.88 $1.7M
Tenaya Therapeutics 0.06% Hold 915,705 $1.62 $1.5M
Hyperfine 0.05% Hold 898,720 $1.45 $1.3M
Exact Sciences 0.05% Hold 23,205 $54.71 $1.3M
AUTL, Autolus Therapeutics 0.05% Hold 698,262 $1.63 $1.1M
GUTS, Fractyl Health 0.04% Hold 662,584 $1.59 $1.1M
ALEC, Alector 0.02% Hold 175,866 $2.96 $521K
Quince Therapeutics 0.01% Hold 189,122 $1.63 $308K
FULC, Fulcrum Therapeutics 0.01% Hold 14,262 $9.20 $131K
RGEN, Repligen 0.00% Hold 383 $133.67 $51K

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top.

Filings history

4 periods, with AUM normalized

Newest 13Fs
Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 28 $99.1B +2367.2% 13F-HR 8/7/2026 000165204426000073
2026 Q1 26 $4B +55.7% 13F-HR 5/8/2026 000165204426000051
2025 Q4 29 $2.6B +7.1% 13F-HR 2/13/2026 000165204426000023
2025 Q3 37 $2.4B — 13F-HR 11/7/2025 000165204425000096

About

Alphabet Inc.

4 processed 13Fs on this site, 2025 Q3 to 2026 Q2

SEC filing name
Alphabet Inc.
Location
Mountain View, CA
All SEC filings
View on sec.gov

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

  • The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
  • One Up On Wall Street (Lynch), Peter Lynch View on Amazon

More on the shelf